Cell & Gene Therapies – CI Perspective
Paul D’Souza-Bento and Alex Bour
The landscape for cell and gene therapies has been evolving over the past few years with a rise in available treatments for rare and life-threatening diseases in the last year alone. This is despite generally high costs of R&D and manufacturing,...
Key Takeaways for CI Teams
Gene Therapy Landscape
Cell Therapy Landscape
Gene and Non-modified Cell Therapies
Deals Trends
Future Revenue Drivers
Consultant’s View
About Evaluate’s CI Consulting Practice